Recent News

• 11.24.2025 - Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
• 11.13.2025 - Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
• 11.03.2025 - Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
• 09.29.2025 - Outlook Therapeutics Provides Update on Type A Meeting with FDA
• 09.29.2025 - Outlook Therapeutics Provides Update on Type A Meeting with FDA

Recent Filings

• 11.13.2025 - 8-K Current report
• 11.03.2025 - 8-K Current report
• 11.03.2025 - EX-99.1 EX-99.1
• 10.21.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities